Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
513.78B | 480.31B | 445.91B | 414.15B | 396.85B | 387.00B | Gross Profit |
137.83B | 121.91B | 117.68B | 108.19B | 102.97B | 97.95B | EBIT |
60.12B | 57.06B | 51.36B | 47.55B | 45.88B | 42.33B | EBITDA |
81.37B | 80.45B | 73.57B | 67.47B | 65.47B | 57.80B | Net Income Common Stockholders |
41.92B | 40.46B | 37.30B | 33.47B | 33.44B | 28.77B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
88.82B | 149.37B | 121.62B | 122.33B | 108.99B | 32.37B | Total Assets |
796.66B | 471.40B | 435.47B | 407.61B | 380.40B | 342.49B | Total Debt |
317.09B | 73.97B | 77.92B | 78.97B | 85.64B | 57.82B | Net Debt |
228.27B | -70.39B | -43.51B | -42.28B | -23.13B | 25.75B | Total Liabilities |
466.58B | 168.49B | 163.07B | 160.25B | 153.06B | 134.41B | Stockholders Equity |
312.55B | 302.25B | 271.91B | 246.92B | 226.87B | 207.71B |
Cash Flow | Free Cash Flow | ||||
47.23B | 58.31B | 29.28B | 45.00B | 32.95B | 36.05B | Operating Cash Flow |
56.85B | 67.90B | 43.59B | 59.08B | 50.22B | 48.95B | Investing Cash Flow |
-268.11B | -19.90B | -14.95B | -14.93B | -20.59B | -27.34B | Financing Cash Flow |
169.09B | -25.88B | -29.07B | -32.34B | -32.49B | -16.31B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $4.38T | 22.99 | 10.13% | 0.85% | -0.91% | 52.93% | |
71 Outperform | ¥1.15T | 27.47 | 1.93% | 8.34% | 4.41% | ||
69 Neutral | $2.39T | 34.02 | 15.31% | 1.58% | 8.65% | 12.22% | |
69 Neutral | $5.30T | 16.77 | 19.16% | 0.95% | 0.40% | 152.61% | |
63 Neutral | ¥1.18T | 22.04 | 14.69% | 2.36% | 13.33% | 12.72% | |
62 Neutral | ¥950.27B | 18.75 | 1.66% | 3.33% | -5.12% | ||
59 Neutral | $9.97B | 10.09 | -6.54% | 3.08% | 7.41% | -11.60% |